Dr. Falk Pharma GmbH

https://www.drfalkpharma.de

LinkedIn: https://www.linkedin.com/company/dr.-falk-pharma

Dr. Falk Pharma GmbH has been developing and marketing innovative medicines to treat a wide range of gastrointestinal disorders like inflammatory bowel disease or eosinophilic esophagitis as well as hepatobiliary disorders such as primary biliary cholangitis for over 60 years. As the international experts in digestive and metabolic medicine, the company brings together physicians, scientists, and patients to devise new and powerful approaches to patient care. Dr. Falk Pharma engages in pre-clinical and clinical stage research that aims to meaningfully improve therapeutic practice as well as patient health and well-being. A family-owned business with a global presence, Dr. Falk Pharma has ten affiliates in Europe and Australia and is continuously growing. The company has its headquarters and R&D facilities in Freiburg, Germany, its pharmaceutical products are manufactured in Europe, mainly at sites in Germany, France, Italy and Switzerland. Dr. Falk Pharma GmbH employs approximately 1250 individuals globally and 323 in Freiburg. *

	Start	1960-01-01 established_pre
	Group	Falk Pharma (Group)
	Industry	pharmaceutical
	Industry 2	gastrointestinal drug
	Person	Falk, Ursula (Dr Falk Pharma 201403 Managing Director)

	Region	Freiburg im Breisgau
	Country	Germany
	Street	5 Leinenweberstr.
	City	79108 Freiburg
	Tel	+49-761-1514-0
		Address record changed: 2024-11-01

Basic data	Employees	F: 1,001 to 5,000 (2024-11-29)

		* Document for »About Section«: Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg.

		Record changed: 2025-03-16

Picture Swiss Biotech Association Global Village 2025 SBD25 Basel 650x200px

More documents for Falk Pharma (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)